U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07859709) titled 'The CLASP III TR CED Study' on Oct. 01.
Brief Summary: This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who received a Transcatheter Tricuspid Valve Repair procedure using the PASCAL Precision system.
Study Start Date: Oct. 15
Study Type: OBSERVATIONAL
Condition:
Tricuspid Regurgitation
Heart Valve Diseases
Heart Diseases
Cardiovascular Diseases
Tricuspid Valve Insufficiency
Intervention:
DEVICE: PASCAL Precision system Treated
Patients 65 years old or older with at least severe Tricuspid Regurgitation who received a Transcat...